CELZ - Biotech Up Massively On Follow-Up Data

2023-04-12 15:24:23 ET

A Phoenix-based %Biotech company put on quite a show on Wednesday as shares experienced quite a bit of volatility on what appears to be the third-most actively traded day for the stock in the last year.

Shares of %CreativeMedicalTechnologyHoldings (Nasdaq: ) rallied strongly on Wednesday following the company announcing positive one-year follow-up data and significant efficacy using CELZ-001 to treat patients with Type 2 Diabetes without any serious adverse effects reported, according to the release.

Traders snatched up shares of this micro cap all the way up to $1.33/share (+174.79%) at the session high. This stock is known to experience some pretty significant whipsaws so be sure to keep an eye on this one!

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is %StemCellResearch and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.